Equites Radar

SBRA · Sabra Health Care REIT, Inc.

REIT - Healthcare FacilitiesUnited StatesAnalyst view: Buy

$22.03

+0.23% last session

End-of-day data · updated 2026-07-25

Bullish5 bullish · 1 bearish technical signals
Consensus: Buy (2.38 from 14 analysts)
To mean target: +3.1%

Market cap

$6B

Enterprise value

$8B

Trailing P/E

35.5

Forward P/E

29.4

Dividend yield

5.0%

Beta

0.63

Avg volume

3M

Employees

0K

2D change

1.50%

5D change

11.80%

10D change

14.55%

30D change

15.79%

60D change

7.50%

MTD change

13.62%

YTD change

21.55%

Analyst Outlook

Consensus ratingBuy
Recommendation mean (1–5)2.38
Covering analysts14
Mean price target$22.71
Low price target$19.00
Upside to mean target+3.1%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)73.4
50-day MA$19.71
200-day MA$19.06
Price vs 50-day MA+11.8%
Price vs 200-day MA+15.6%
MACD histogram0.26
Volume vs 3-month avg1.1×
52w low $16.4752w high $22.04

Analyst sentiment over time — SBRA

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-07-22

Latest call per bank · past 12 months

UBS

Neutral

$21.00

-4.7% vs price
▼ cut from $22.00Maintains · 2026-07-08

Barclays

Equal-Weight

$21.00

-4.7% vs price
▲ raised from $0.00Initiates · 2026-07-07

Citigroup

Neutral

$19.00

-13.8% vs price
▼ cut from $24.00Downgrade · 2026-06-23

Wells Fargo

Overweight

$23.00

+4.4% vs price
▲ raised from $22.00Maintains · 2026-06-01

Recent rating actions

DateFirmActionRatingPrice target
2026-07-22BairdMaintainsNeutral$22.00 $23.00
2026-07-22Truist SecuritiesMaintainsBuy$22.00 $24.00
2026-07-22CitizensMaintainsMarket Outperform$23.00 $25.00
2026-07-08UBSMaintainsNeutral$22.00 $21.00
2026-07-08Truist SecuritiesUpgradeHoldBuy$22.00
2026-07-07BarclaysInitiatesEqual-Weight$0.00 $21.00
2026-06-23CitigroupDowngradeBuyNeutral$24.00 $19.00
2026-06-18ScotiabankMaintainsSector Perform$22.00 $19.00

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-07-23

  • RSI (14): RSI is 73 — overbought territory; the recent run-up may be due for a pause.
  • Price vs 50-day MA: Trading 11.8% above the 50-day MA ($19.71).
  • Price vs 200-day MA: Trading 15.6% above the 200-day MA ($19.06).
  • MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
  • MACD (12,26,9): MACD histogram is positive (+0.26) — short-term momentum is improving.
  • 52-week range: Price is within 5% of the 52-week high ($22.04).

SBRA Price Chart

Loading chart for SBRA

Fundamentals

Revenue (TTM)$1.0B
EBITDA$0M
Free cash flow$0M
Operating cash flow$0M
Book value / share$11.05
Net debt / EBITDA5.6
WACC8.0%
Revenue growth22.00%
Earnings growth-6.00%

About Sabra Health Care REIT, Inc.

Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Health Care REIT, Inc. is incorporated on May 10th, 2010 and is based in Tustin, United States.

More in REIT - Healthcare Facilities

Screen SBRA against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.